Dr. Caner Geyik, member of Faculty of Medicine, Department of Medical Biochemistry, has been appointed to the “Pharmacological regulation and drugs’’ Working Group of COST Action CA20121 titled “Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases’’.
Congratulations to Dr. Caner Geyik and we wish him continued success